155 related articles for article (PubMed ID: 8772790)
21. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
Hansmann ML; Stein H; Dallenbach F; Fellbaum C
Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
23. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactivities of Reed-Sternberg cells and their variants in the sequential biopsy of Hodgkin's disease.
Ohsawa M; Aozasa K; Ikeda H
Mod Pathol; 1993 Jul; 6(4):457-62. PubMed ID: 8415592
[TBL] [Abstract][Full Text] [Related]
25. Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay.
Delabie J; Tierens A; Wu G; Weisenburger DD; Chan WC
Blood; 1994 Nov; 84(10):3291-8. PubMed ID: 7949084
[TBL] [Abstract][Full Text] [Related]
26. Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL.
Küppers R; Sousa AB; Baur AS; Strickler JG; Rajewsky K; Hansmann ML
Mol Med; 2001 May; 7(5):285-92. PubMed ID: 11474574
[TBL] [Abstract][Full Text] [Related]
27. Chronic lymphocytic leukemia with coexistent Hodgkin's disease. Implications for the origin of the Reed-Sternberg cell.
Williams J; Schned A; Cotelingam JD; Jaffe ES
Am J Surg Pathol; 1991 Jan; 15(1):33-42. PubMed ID: 1670753
[TBL] [Abstract][Full Text] [Related]
28. Antiapoptotic marker Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12.
Chu WS; Aguilera NS; Wei MQ; Abbondanzo SL
Hum Pathol; 1999 Sep; 30(9):1065-70. PubMed ID: 10492041
[TBL] [Abstract][Full Text] [Related]
29. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
30. The distinction of Hodgkin's disease from B cell lymphoma.
Warnke RA
Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
[TBL] [Abstract][Full Text] [Related]
31. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin's disease associated with chronic lymphocytic leukemia. Eight additional cases, including two of the nodular lymphocyte predominant type.
Weisenberg E; Anastasi J; Adeyanju M; Variakojis D; Vardiman JW
Am J Clin Pathol; 1995 Apr; 103(4):479-84. PubMed ID: 7726147
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma.
Sextro M; Diehl V; Franklin J; Hansmann ML; Anagnostopoulos I; Marafioti T; Stein H
Ann Oncol; 1996; 7 Suppl 4():61-5. PubMed ID: 8836412
[TBL] [Abstract][Full Text] [Related]
34. [Classical Hodgkin's lymphoma: biology and grey zones].
Gaulard P; Brousse N
Ann Pathol; 2004 Sep; 24(4):330-48. PubMed ID: 15567950
[TBL] [Abstract][Full Text] [Related]
35. Clonal identification of Burkitt's lymphoma arising from lymphocyte-predominant Hodgkin's disease.
Yoshinaga H; Ohashi K; Yamamoto K; Miki T; Miura O; Saito T; Koyama T; Kanazawa A; Nemoto T; Miyasaka N; Kamiyama R; Hirosawa S
Br J Haematol; 1996 Nov; 95(2):380-2. PubMed ID: 8904897
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances.
Franke S; Wlodarska I; Maes B; Vandenberghe P; Delabie J; Hagemeijer A; De Wolf-Peeters C
Blood; 2001 Mar; 97(6):1845-53. PubMed ID: 11238128
[TBL] [Abstract][Full Text] [Related]
37. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte predominance Hodgkin's disease--an immunohistochemical study.
Nicholas DS; Harris S; Wright DH
Histopathology; 1990 Feb; 16(2):157-65. PubMed ID: 2323737
[TBL] [Abstract][Full Text] [Related]
39. IgH and TcR-gamma gene rearrangements identified in Hodgkin's disease by PCR demonstrate lack of correlation between genotype, phenotype, and Epstein-Barr virus status.
Al Saati T; Galoin S; Gravel S; Lamant L; Roda D; Chittal SM; Delsol G
J Pathol; 1997 Apr; 181(4):387-93. PubMed ID: 9196435
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous nodular lymphocyte predominance Hodgkin's disease (N-LPHD) and large-cell lymphoma (LCL).
Whittaker M; Fomcar K; Keith T; McAneny B
Am J Surg Pathol; 1989 Aug; 13(8):715-6. PubMed ID: 2787607
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
